These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11414657)

  • 21. Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells.
    Mahé C; Loetscher E; Dev KK; Bobirnac I; Otten U; Schoeffter P
    Neuropharmacology; 2005 Jul; 49(1):40-7. PubMed ID: 15992579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea pig hippocampal membranes.
    Shenker A; Maayani S; Weinstein H; Green JP
    Mol Pharmacol; 1987 Apr; 31(4):357-67. PubMed ID: 2952874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.
    Zgombick JM; Schechter LE; Adham N; Kucharewicz SA; Weinshank RL; Branchek TA
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):226-36. PubMed ID: 8878051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT7 receptor-mediated relaxation of the oviduct in nonpregnant proestrus pigs.
    Inoue M; Kitazawa T; Cao J; Taneike T
    Eur J Pharmacol; 2003 Feb; 461(2-3):207-18. PubMed ID: 12586216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with Galphas- and Galphai/o-proteins.
    Pindon A; van Hecke G; van Gompel P; Lesage AS; Leysen JE; Jurzak M
    Mol Pharmacol; 2002 Jan; 61(1):85-96. PubMed ID: 11752209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
    Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR
    Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties.
    Rauly-Lestienne I; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Cussac D
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Oct; 376(1-2):93-105. PubMed ID: 17786406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
    Brüss M; Molderings GJ; Bönisch H; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
    Khawaja X; Ennis C; Minchin MC
    Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum.
    Hemedah M; Coupar IM; Mitchelson FJ
    Br J Pharmacol; 1999 Jan; 126(1):179-88. PubMed ID: 10051134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines.
    Mialet J; Berque-Bestel I; Eftekhari P; Gastineau M; Giner M; Dahmoune Y; Donzeau-Gouge P; Hoebeke J; Langlois M; Sicsic S; Fischmeister R; Lezoualc'h F
    Br J Pharmacol; 2000 Feb; 129(4):771-81. PubMed ID: 10683202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells.
    Mialet J; Berque-Bestel I; Sicsic S; Langlois M; Fischmeister R; Lezoualc'h F
    Br J Pharmacol; 2000 Oct; 131(4):827-35. PubMed ID: 11030734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impairment of signal transduction in response to stimulation of the naturally occurring Pro279Leu variant of the h5-HT7(a) receptor.
    Kiel S; Bönisch H; Brüss M; Göthert M
    Pharmacogenetics; 2003 Feb; 13(2):119-26. PubMed ID: 12563181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing.
    Heidmann DE; Szot P; Kohen R; Hamblin MW
    Neuropharmacology; 1998 Dec; 37(12):1621-32. PubMed ID: 9886685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
    Newman-Tancredi A; Verrièle L; Millan MJ
    Br J Pharmacol; 2001 Jan; 132(2):518-24. PubMed ID: 11159702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unaltered agonist potency upon inducible 5-HT7(a) but not 5-HT4(b) receptor expression indicates agonist-independent association of 5-HT7(a) receptor and Gs.
    Bruheim S; Krobert KA; Andressen KW; Levy FO
    Recept Channels; 2003; 9(2):107-16. PubMed ID: 12916471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
    Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA
    Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells.
    Boess FG; Monsma FJ; Carolo C; Meyer V; Rudler A; Zwingelstein C; Sleight AJ
    Neuropharmacology; 1997; 36(4-5):713-20. PubMed ID: 9225298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms.
    Lovenberg TW; Baron BM; de Lecea L; Miller JD; Prosser RA; Rea MA; Foye PE; Racke M; Slone AL; Siegel BW
    Neuron; 1993 Sep; 11(3):449-58. PubMed ID: 8398139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological characterisation of 5-HT receptors positively coupled to adenylyl cyclase in the rat hippocampus.
    Markstein R; Matsumoto M; Kohler C; Togashi H; Yoshioka M; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):454-9. PubMed ID: 10431755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.